Journal of Cardiothoracic and Vascular Anesthesia
Volume 24, Issue 2 , Pages 217-218 , April 2010

Can Meta-analysis of the Current Literature Help Determine if Perioperative β-Blockers Improve Outcome of High-Risk Patients Undergoing Noncardiac Surgery?

References 

  1. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. N Engl J Med. 1996;335:1713–1720
  2. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. N Engl J Med. 1999;341:1789–1794
  3. Poldermans D, Boersma E, Bax JJ, et al. Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. Eur Heart J. 2001;22:1353–1358
  4. POBBLE Trial Investigators. Perioperative b-blockade (POBBLE) for patients undergoing infrarenal vascular surgery: Results of a randomized double-blind controlled trial. J Vasc Surg. 2005;41:602–609
  5. Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative b blockade in patients with diabetes undergoing major non-cardiac surgery: Randomized placebo controlled blinded multicentre trial. BMJ. 2006;332:1482–1489
  6. Yang H, Raymer K, Butler R, et al. The effects of perioperative b-blockage: Results of the Metoprolol after Vascular Surgery (MaVS) study, a randomized controlled trial. Am Heart J. 2006;152:983–990
  7. POISE Study Group. Effects of extended release metoprolol succinate in patients undergoing non-cardiac surgery (POISE TRIAL): A randomized controlled trial. Lancet. 2008;31:1839–1847
  8. Dunkelgrun M, Boersma E, Schouten O, et al. Bisoprolol and fluvastatin for the reduction of perioperative cardiac mortality and myocardial infarction in intermediate-risk patients undergoing noncardiovascular surgery: A randomized controlled trial (DECREASE-IV). Ann Surg. 2009;249:921–926
  9. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med. 2005;353:349–361
  10. Landoni G, Turi S, Biondi-Zoccai G, et al. Esmolol reduces perioperative ischemia in non-cardiac surgery: A meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2010;24:219–229
  11. Raby KE, Brull SJ, TImimi , et al. The effect of heart rate control on myocardial ischemia among high risk patients after vascular surgery. Anesth Analg. 1999;88:477–482
  12. Korpinen R, Simola M, Saarnivarra L. Effect of esmolol on the hemodynamic and electrocardiographic changes during laryngomicroscopy under propofol/alfentanil anesthesia. Acta Anaesthesiol Belg. 1998;49:123–132
  13. Korpinen R, Simola M, Saarnivarra L. Effect of esmolol on the heart rate, arterial pressure and electrocardiographic changes during laryngomicroscopy. Acta Anaesthesiol Scand. 1997;41:371–375
  14. Maguire A, Thompson JP, Guest C, et al. Comparison of the effects of intravenous alfentanil and esmolol on the cardiovascular response to double-lumen endobronchial intubation. Anaesthesia. 2001;56:319–325

PII: S1053-0770(10)00018-2

doi: 10.1053/j.jvca.2010.01.014

Journal of Cardiothoracic and Vascular Anesthesia
Volume 24, Issue 2 , Pages 217-218 , April 2010

Article Tools